Assembly Biosciences Inc (V7B)

Frankfurt
Currency in EUR
14.250
+0.150(+1.06%)
Closed
V7B Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
14.10014.250
52 wk Range
9.22817.950
Key Statistics
Edit
Bid/Ask
14.00 / 14.50
Prev. Close
14.25
Open
14.1
Day's Range
14.1-14.25
52 wk Range
9.228-17.95
Volume
912
Average Volume (3m)
816
1-Year Change
44.99%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
V7B Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Assembly Biosciences Inc Company Profile

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Compare V7B to Peers and Sector

Metrics to compare
V7B
Peers
Sector
Relationship
P/E Ratio
−2.3x−2.0x−0.6x
PEG Ratio
−0.04−0.010.00
Price/Book
3.6x1.6x2.6x
Price / LTM Sales
3.3x9.2x3.1x
Upside (Analyst Target)
-187.8%53.1%
Fair Value Upside
Unlock25.8%7.5%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

3.49
SANA
-0.29%
11.08
RCKT
+5.73%
35.38
AGIO
+3.88%
15.1600
GRRR
-1.37%
0.871
SPRO
0.00%

FAQ

What Is the Assembly Biosciences (V7B) Stock Price Today?

The Assembly Biosciences stock price today is 14.25

What Stock Exchange Does Assembly Biosciences Trade On?

Assembly Biosciences is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Assembly Biosciences?

The stock symbol for Assembly Biosciences is "V7B."

What Is the Assembly Biosciences Market Cap?

As of today, Assembly Biosciences market cap is 90.46M.

What is Assembly Biosciences Earnings Per Share?

The Assembly Biosciences EPS is -7.16.

From a Technical Analysis Perspective, Is V7B a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.